Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 64
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Psychedelics in Palliative Care: Screening, Safety Measures, and Experiences With the...
When Data Meets Doubt: Investigating the FDA Panel’s Rejection of MDMA
Psychedelic Research: The Current Landscape and Future Directions
Understanding Bad Trips: The Power and Potential of Adverse Psychedelic Experiences
Pα+ Psychedelic Bulletin #168:
Ecopsychology, Plant Dietas, and Plant Consciousness: Building a Relationship with Nature
Women’s Health and Psychedelics – New Insights
Regenerative Business in Psychedelics: A Sustainable Path Forward
Meditation, Exploring Spiritual Traditions, and the Wisdom of Plant Medicine
Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking
Load more